Stay updated on CAR-T for CD33+ AML Clinical Trial

Sign up to get notified when there's something new on the CAR-T for CD33+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAR-T for CD33+ AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record describes a Phase 1 study of CD33-CAR-T therapy for relapsed or refractory acute myeloid leukemia. It states that the study was terminated at the principal investigator’s request and is no longer looking for participants.
    Difference
    57%
    Check dated 2026-11-08T00:04:25.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.2 to v3.8.0, while the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T17:54:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T22:25:54.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision number in the footer changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:24:39.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T22:15:22.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, replacing the navigation and study details with an error screen. This blocks access to the trial information on the page.
    Difference
    20%
    Check dated 2026-09-19T20:32:55.000Z thumbnail image

Stay in the know with updates to CAR-T for CD33+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAR-T for CD33+ AML Clinical Trial page.